Whole Earth Gifts https://www.wholeearthgifts.com/ Premium Quality Kratom at the Markets Most Competitive Prices Sat, 26 Dec 2020 18:32:05 +0000 en-US hourly 1 https://wordpress.org/?v=6.6.2 https://www.wholeearthgifts.com/wp-content/uploads/2020/08/cropped-WEG-Transparent-150x150.png Whole Earth Gifts https://www.wholeearthgifts.com/ 32 32 Restaurant in North Carolina adds Kratom to the menu https://www.wholeearthgifts.com/restaurant-adds-kratom/ https://www.wholeearthgifts.com/restaurant-adds-kratom/#respond Fri, 30 Oct 2020 14:25:19 +0000 https://www.wholeearthgifts.com/?p=10466 The post Restaurant in North Carolina adds Kratom to the menu appeared first on Whole Earth Gifts.

]]>

EMMY TRIVETTE | The Daily Tar Heel | 10.30.20

Linda’s to add breakfast, coffee, alcohol alternatives to its menu

Linda's to add breakfast, coffee, alcohol alternatives to its menu 

Customers have a drink outside the recently reopened Linda’s Bar and Grill on Franklin Street on Tuesday, Oct. 27, 2020.

Restaurant adds kratom

Linda’s Bar and Grill, one of Chapel Hill’s most frequented restaurants, reopened last week and now plans to begin serving breakfast in addition to its classic specials like loaded tots.

The restaurant, which closed in August due to COVID-19 complications, will update its menu with everything from a Linda’s Breakfast —two eggs any style — to french toast, bagels and pancakes with sides.

Linda’s owner Chris Carini said this is the second time he has basically started the restaurant from nothing after the University’s brief reopening and closing in August.

“I wish the University would have done a better job because they cost a lot of people, a lot of money,” Carini said.

Carini said the University closing in August after a week of classes cost his business about $50,000. So after selling most of his belongings to make up for the lost money, Carini said he is now happy to say the bar and grill has officially reopened.

Linda’s is open Tuesday through Saturday from 11:30 a.m. to 10 p.m., with window service and outdoor seating options. Starting next week, it will be open at 10 a.m. to serve breakfast.

“I was like, ‘Holy crap that’s the idea, that’s the one, that’s how we do it,’” Carini said. “That’s how we get people to come back and then we don’t have to be open till four in the morning.”

George Hanna, a Linda’s regular, has been coming to the bar and grill since 2011, around the same time Carini bought the place. Hanna lives in Raleigh, but said a Linda’s breakfast might be worth a special trip to Chapel Hill.

“Every time they come out with something new, as far as the food goes, it’s been fantastic,” Hanna said.

The Linda’s menu will also include diverse coffee options. Carini hopes when the cold weather comes, Linda’s downbar will be able to open for those who are looking for a quiet space to study and get their daily dose of caffeine.

Alongside the breakfast and coffee, Carini said he’s including plant-based supplements kratom and kava, to mix with tea or other non-alcoholic drinks the eatery offers.

Carini’s friend, Jacob Torbert, pitched the kratom and kava idea. As a military veteran, Torbert said he’s found more and more people who aren’t interested in the big partying and drinking culture that normally surrounds military involvement.

“One of the big reasons I got into kava and kratom was because I found it just helped me a lot with some of the things I was experiencing,” Torbert said. “It tends to help me with pain, it gives me a little bit more energy, it helps me focus. I feel like it helps make me more productive.”

Restaurant adds kratom

Kratom alerts or focuses the consumer, while kava acts as more of a relaxer. The two hit the same receptors as drugs or alcohol without the intoxicating effects, creating an alternative for those who may want to avoid certain substances.

Carini said the kratom and kava options offer an opportunity for those who don’t want to drink to still be social in a bar environment. It may take a little bit for the new options to catch on, but Carini said he thinks they should draw in a large crowd once they do.

“I get to help my buddy, and some of his brothers in arms, I get to help some college students to ‘get their learn on’ and hopefully give them another place to hang out,” Carini said. “And it keeps us open, which at the end of the day, that’s really all we got to do.”

@EmmyTrivette

@DTHCityState | city@dailytarheel.com 

Restaurant adds kratom

 

Home | Shop | Brands | Lab Tests | FAQ | Contact
Twitter | Facebook | Instagram | Youtube | Pinterest
1836 Kratom | Super Speciosa | KR8om | America Kratom Association | Kratomaton.com

The post Restaurant in North Carolina adds Kratom to the menu appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/restaurant-adds-kratom/feed/ 0
American Kratom Association | Top 10 Reasons for Kratom https://www.wholeearthgifts.com/american_kratom_association_top-10-reason/ https://www.wholeearthgifts.com/american_kratom_association_top-10-reason/#respond Fri, 23 Oct 2020 15:51:39 +0000 https://wholeearthgifts.com/?p=3409 The post American Kratom Association | Top 10 Reasons for Kratom appeared first on Whole Earth Gifts.

]]>

American Kratom Association

Top 10 Reasons for Kratom: Full Top 10

Introducing the top 10 reasons kratom should not be classified as a schedule I drug or banned by any state or local government.
Each day we will share another reason, and ask that you read and share with friends and family to share how #KratomSavesLives
American Kratom Association
#KRATOM
 CONSUMERS – #KRATOMSAVESLIVES Hear the voices of kratom consumers
Kratom Consumers Tell Their Stories
vimeo.com/showcase/kratomsaveslives

1) Nora Volkow, Director of the National Institute on Drug Abuse (NIDA) thinks we should be studying kratom – not classifying it as a Schedule I drug.

Dr. Volkow points to exciting new basic science that “point toward the potential of this drug [kratom] in pain research as well as the need for further research on the pharmacology of kratom’s constituents, their toxicity and potential value in the treatment of Opioid Use Disorder (OUD)”

Dr. Volkow previously testified to Congress that when a substance gets a Schedule I, it makes research much harder.

NIDA. 2020, July 7. Reviewing NIDA’s 2019 Achievements and Looking to the Future.

American Kratom Association 10 reasons not to ban kratom One

2) Albert Garcia-Romeu, PhD, faculty member at Johns Hopkins University School of Medicine conducted research showing kratom is significantly helping people with opioid dependence

Dr. Garcia-Romeu’s research reports that 87% of U.S. adult kratom consumers treating opioid dependence with kratom reported relief from withdrawal symptoms – and 35% were free from opioids >1 year.

Kratom consumers reported low incidence of severe side effects, and low severity of kratom substance use disorder.

American Kratom Association 10 reasons not to ban kratom 2

3) NIDA funded kratom animal studies found no significant addition liability — Scott Hemby, PhD and his team led one study, and Kai Yue led the NIDA team study

Both studies suggested a limited abuse liability of mitragynine and potential for kratom to be a treatment to reduce opioid abuse because it lowered morphine intake by the test animals.

The criteria for scheduling under the Controlled Substances Act requires the substance to have high abuse potential. American Kratom Association

American Kratom Association 10 reasons not to ban kratom 3

4) Jane Babin, PhD, JD, conducted an extensive analysis of the deaths the FDA claimed were associated with kratom and found all the deaths were the result of polydrug use or adulterated kratom products, and found the FDA claims to be unreliable.

None of the death reports claimed by the FDA provides a cohesive or reasonable scientific basis to conclude any of the deaths was caused by kratom, nor does the information released conclusively support any conclusion that kratom was associated to the cited death other than coincidentally. (The FDA Kratom Death Data: Exaggerated Claims, Discredited Research, and Distorted Data Fail to Meet the Evidentiary Standard for Placing Kratom as a Schedule I Controlled Substance, March 2018) American Kratom Association

American Kratom Association 10 reasons not to ban kratom 4

5) NIDA concludes “There have been multiple reports of deaths in people who had ingested kratom, but most have involved other substances . . . there have been some reports of kratom packaged as dietary supplements or dietary ingredients that were laced with other compounds that caused deaths.”

https://www.drugabuse.gov/publications/drugfacts/kratom

CDC reported postmortem toxicology testing detected multiple substances for almost all decedents, including Fentanyl and fentanyl Analogs, Heroin, prescription opioids and cocaine.

10 reasons not to ban kratom Final dragged 5

6) The FDA insists kratom has the same effects as classic opioids, but leading scientists, including Andrew Kruegel, PhD, of Columbia University disagree:

“Kratom doesn’t seem to share the dangerous side effect of respiratory depression that other opioids have—that’s when someone’s breathing slows down and could stop completely. Better understanding how certain opioids produce certain effects is key to developing safer painkillers . . . The problem with saying it’s ‘an opioid’ without qualification is that it just paints everything with this broad brush, and obviously carries a negative connotation given what’s going on in the country right now.”

https://www.vice.com/en_us/article/neqn4b/fda-declared-kratom-an-opioid

10 reasons not to ban kratom Final dragged 6

7) The U.S. Congress FY2020 and 2021 Budget Bills call for more research on kratom and recognize its value in the fight against the opioid crisis in America.

The Committee encourages NIDA to expand research on all health impacts of kratom, including its constituent compounds, mitragynine and 7- hydroxymitragynine. The Committee is aware of the potential promise of kratom- derived compounds for acute and chronic pain patients who seek safer alternatives to sometimes dangerously addictive and potentially deadly prescription opioids. American Kratom Association

10 reasons not to ban kratom Final dragged 7

8) Jack Henningfield, PhD, adjunct professor at Johns Hopkins University, conducted research with a team of investigators showing risks of overdose deaths are many magnitudes higher with opioids than with kratom.

“By any of our assessments, it appears that the risk of overdose death is >1000 times greater for opioids than for kratom”

kratom top 10 2

9) Individual states are enacting appropriate regulations to protect consumers from dangerously adulterated kratom products.

Four states have enacted the Kratom Consumer Protection Act (KCPA) and 21 states were considering passage in 2020 before the COVID-19 shutdown. The KCPA requires (1) kratom manufacturers to follow current good manufacturing processes; (2) no dangerous adulterants or synthesized kratom alkaloids; (3) no alteration of the natural plant alkaloid content; (4) labels showing consumers contents of kratom products; and appropriate limits restricting sales to minors.

10 reasons not to ban kratom Final dragged 9

10)#KRATOM CONSUMERS – #KRATOMSAVESLIVES

Hear the voices of kratom consumers. Kratom Consumers Tell Their Stories

 

Super Speciosa 1836 Kratom American Kratom Association KR8om

The post American Kratom Association | Top 10 Reasons for Kratom appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/american_kratom_association_top-10-reason/feed/ 0
Meet Christopher McCurdy, Researcher Who Could Determine Future of Kratom https://www.wholeearthgifts.com/meet-christopher-mccurdy-researcher-who-could-determine-future-of-kratom/ https://www.wholeearthgifts.com/meet-christopher-mccurdy-researcher-who-could-determine-future-of-kratom/#respond Mon, 19 Oct 2020 12:00:28 +0000 https://www.wholeearthgifts.com/?p=8773 The post Meet Christopher McCurdy, Researcher Who Could Determine Future of Kratom appeared first on Whole Earth Gifts.

]]>

Future of Kratom… 

DECEMBER 13, 2019 6:28AM

Meet Christopher McCurdy, Researcher Who Could Determine Future of Kratom

Future of Kratom

Christopher McCurdy during a 2017 address at a U.K. conference on the ethnopharmalogic search for psychoactive drugs.

Christopher McCurdy during a 2017 address at a U.K. conference on the ethnopharmalogic search for psychoactive drugs.

Proponents tout Kratom, a popular herbal substance of Southeast Asian origin, as a potentially life-changing pain reliever that can help those hooked on opioids kick their dangerous habits. Other users claim that kratom is also addictive and suggest that its effects are nearly as problematic as the narcotics they’d been trying to leave behind — which explains why it continues to be targeted by the federal Food and Drug Administration.

The FDA has even taken part in the seizure of a shipment bound for Denver, where the city’s health department banned kratom for human consumption in late 2017. But despite such actions, the herb is currently selling by the ton in Colorado.

So is kratom a miracle drug that could follow the trail toward greater acceptance blazed by medical marijuana? Or will it trigger a countrywide crackdown that could drive the product underground?

The man most likely to provide the answers to these questions is Christopher McCurdy, a professor of medical chemistry for the University of Florida College of Pharmacy. If there’s one person in the United States who’ll determine whether kratom remains in the legal shadows in this country or becomes a fully regulated substance whose sales are authorized from coast to coast, it’s him.

Why? Since December 2018, McCurdy’s UF institution has received two grants from the National Institute on Drug Abuse totaling $6.9 million to study the various effects of kratom and its alkaloids, and McCurdy is the lead investigator in these analyses. If his findings suggest medical efficacy, additional research of the sort that could result in an eventual blessing from the feds is all but assured. But should he and his colleagues determine that the risks outweigh the benefits, the movement to mainstream kratom may well be doomed.

At this point, McCurdy, who rarely gives interviews, isn’t tipping his hand in terms of which way he’s leaning. “Right now, our approach is, ‘Let’s get the science. Let’s see what it tells us,'” he says. “If science tells us it’s bad news, we’ll definitely report that. But if the science tells us there’s great potential, or some potential, to help those suffering from addiction, we definitely want to tap that and find out as much as we can.”

Kratom advocates believe this verdict is already in. Mac Haddow, senior fellow on public policy with the American Kratom Association, who is currently pitching legislation dubbed the Kratom Consumer Protection Act in Colorado and other states, told us, “The science resonates. The science is so powerful in terms of kratom’s potential beneficial effects, and that it’s safe.”

Still, Faith Day, the founder and co-owner of Lakewood’s Clean Kratom Wellness Center, sees the need for the kind of oversight that could flow from McCurdy’s research. In her words, “There’s just a lot of sketchy players out there. We need the government to be able to work with the kratom community so we can provide safe access to this product. It’s been put in such a bad light because of all of these issues: contamination issuesheavy metals.”

For his part, McCurdy didn’t set out to become the key to kratom. “I’ve been involved for a long time in health care and research,” he says. “I started life as a pharmacist and decided to go to graduate school after I had some research experience in pharmacy school.

McCurdy entered graduate school and worked on treatments for Alzheimer’s disease and nicotine dependence through a natural product called lobeline, he says. “That got me interested in going on and doing a post-doctoral fellowship with a guy named Phil Portoghese at the University of Minnesota. He was one of the fathers of opioid chemistry and really helped to define the opioid systems as we know them today. I learned from him that you can essentially spend an entire year on a molecule or a plant.”

The knowledge of molecular biology and pharmacology and the opioid system made him think that if he could try to come up with drugs to treat dependence, he could carve out a career. Future of Kratom

Over the course of his work, McCurdy continues, “I came across a compound called salvia before much was published about it. I found it to be a kappa-opioid receptor antagonist and a potent hallucinogen. Years later, there was a big YouTube craze because of a video showing Miley Cyrus smoking the stuff. I was funded by the National Institute on Drug Abuse to study that, and I was invited by officials at NIDA to give a presentation on naturally occurring opioid compounds. I started digging into the literature and looking to see what might have been published — and that’s when I came across kratom. It was probably 2004,” when he was a staffer at the University of Mississippi School of Pharmacy.

Christopher McCurdy, right, examines a flash of kratom with his late wife and fellow researcher, Bonnie Avery.

Christopher McCurdy, right, examines a flash of kratom with his late wife and fellow researcher, Bonnie Avery.

He soon realized “there was something very interesting about this plant and the alkaloids within it. It was relatively unexplored from a scientific perspective, so we didn’t know if there was any legitimacy about the claims made over the years about it either warding off withdrawals after people ran out of opiates in Thailand and Mali, where it had been traditionally used, or if it was helpful for people trying to wean themselves off illicit opioid use. I was interested in that early on.”

So, too, is Roxanne Gullikson, facility director for Portland, Maine’s Greener Pastures Holisticare, a residential treatment center that uses kratom as part of a formal and comprehensive addiction treatment regimen, as well as follow-up care. “We have counseled patients in recovery facing a surgery who are terrified of waking up with a morphine pump in their arm — afraid that it could send them back into active addiction,” she told us last year. “And this has happened. We’ve had patients tell their doctor, ‘I can’t do opiates. It would be dangerous.’ And then they wake up with pain medication connected to them. So having a supply of kratom on hand to address their pain can be very important.” Future of Kratom

To see if he could replicate such effects, McCurdy made contact with a kratom vendor and purchased “a single batch from the same harvest — 25 kilos of leaf material that we’ve been using for about the last fifteen years. I hadn’t gotten a lot of funding at that point, but we started trying to isolate out these different alkaloids to see if they actually had analgesic activities. Were they similar to morphine? Were they less or more potent? There had only been a few papers that highlighted some of the chemistry over the years, so I wanted to replicate what was already in the literature and start understanding if these compounds had some possible treatment potential for addiction.”

Progress was slow in part because “I was basically using my own startup funds,” he explains. “I had a little support from a grant we had. But no one was really interested in kratom. They thought it was this strange thing out there and didn’t really feel there was potential behind it to study, because it was probably just another opioid, and we don’t need another opioid. That argument still goes on — but I think the real research that’s needed is going to involve humans, and that will take a long time.”

Indeed, McCurdy reveals that he tried to launch human clinical trials related to kratom way back in 2008, but “everything came to a grinding halt when they found we couldn’t say where our raw material was going to come from. That’s one of the greatest problems in advancing the research, and it’s going to be there until we can get authenticated and unadulterated kratom that hasn’t been exposed to pesticides or chemicals. These are tricky things, and having a chain of custody for that material will be problematic, because everything has to be imported into the U.S.”

True enough — and vendors have the same issue. Clean Kratom Wellness Center’s Day notes that “we are not directly importing from Indonesia. That’s illegal. We’re buying it from inside the country from companies that provide us with lab testing. But not everyone does.”

The two NIDA grants, which McCurdy describes in musical terms (“In one, we study each individual instrument, and in the other, we study the whole symphony”), have provided opportunities to get around some of these issues. For instance, he divulges, ‘We’ve started growing trees at the University of Florida. The Environmental Horticulture department is involved in this process, and we’re really starting to get an understanding of how these plants are growing, what the biochemical pathways are for synthesis, and how it can be influenced. And if we want to do a clinical product — if we can grow it from seed to commercial product — then we have a chain of custody control. That’s where I think we’re really going to make some progress and find out if we can really get to human trials. NIDA is very interested in taking mitragynine, the major alkaloid, and developing it for human clinical trials as quickly as we can, to see if it can aid with opioid cessation and trying to address the opioid crisis.”

In the meantime, McCurdy and his team are “studying the individual alkaloids within the plant, because the chain of custody doesn’t really matter in that. We’re taking leaf material or extracts we’ve purchased from various sources in the U.S., and we’re able to isolate each compound in large quantities, so we can understand how the individual alkaloids from the plant can affect an animal — rats, specifically, but we’ve also started doing some studies with beagle dogs — that’s metabolizing the compound and ultimately getting the compound out of its system. Our ultimate goal is to get this to human testing one way or another, either by purified alkaloids that can go into individual drugs, or to see if these individual compounds have real potential that can be explored and fed into some sort of standardized botanical or formulated product.”Future of Kratom

Oliver Grundmann, another University of Florida prof, is contributing knowledge about how kratom is being consumed in America today. “He published one of the largest surveys done of kratom users,” McCurdy notes, “and the majority of them said they used it to improve mood, as well as to stay off of legal or illicit opioids — and some used it for chronic pain treatment. But there’s a huge difference between how it’s used here and how it’s used in Southeast Asia. Here, the products are all made from dried leaf material, and the drying process of the leaf is changing the chemistry and composition of the leaf. I can’t tell you exactly how or to what extent, but we’ve analyzed freshly prepared teas from Mali, and the chemical profiles are different from teas we’ve made from leaf material purchased in the U.S.”Future of Kratom

Earlier this year, McCurdy visited Mali and saw “people picking leaves fresh off the tree. Then they’d put them into low boiling water for three or four hours until they’re reduced down, and use the tea that they brewed throughout the day, usually in 500 milliliter bottles. They’ll pour it out and use that bottle throughout the day, diluting it half and half — half juice with half warm water. And they’ll use it between three and six times a day. That’s why people compare it to coffee — because traditional use is really similar to the way we in the U.S. consume coffee or tea. And the tree itself is in the coffee family.” Future of Kratom

Regarding charges that kratom is habit-forming, McCurdy cites java again. “In Southeast Asia, it’s socially acceptable to drink this tea, just like it is here with coffee — and they’re both addictive in that setting. If some people don’t get their coffee, they get withdrawal symptoms, and that’s pretty much what happens in Southeast Asia with mitragyna speciosa [kratom’s scientific moniker]. They get a bad feeling or a headache or something like that. But because the products are different in the U.S., that may be different, too — because it’s become a whole other beast.”

For this reason, McCurdy doesn’t fault the feds for their kratom cautiousness. “I think the FDA and the DEA [Drug Enforcement Administration] and the CDC [Centers for Disease Control and Prevention] are doing what they need to be doing to protect the public. We don’t understand the science behind the products on the market. We don’t know how many of them are truly mitragyna speciosa, even though they’re labeled that way, and we don’t know how safe these products are from a bacterial or fungal or pesticide or heavy-metal standpoint. A lot of vendors are not testing these materials. They’re just buying it straight from the importer and repackaging and selling it without paying attention to any of the good manufacturing processes that are really required for botanical supplements. There’s a huge industry trying to make a buck off that because it’s the latest fad, and that’s a sad thing. Somebody has to step in and regulate the process.”

Haddow, Day and Gullikson want that, too. But McCurdy stresses that “those of us in the science field want to make sure there’s a scientific basis for any type of decisions that will be made in either making this a scheduled substance or advancing it into further human clinical research.”

Future of Kratom

The post Meet Christopher McCurdy, Researcher Who Could Determine Future of Kratom appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/meet-christopher-mccurdy-researcher-who-could-determine-future-of-kratom/feed/ 0
American Kratom Association | Kratom Top 10 Answers https://www.wholeearthgifts.com/american-kratom-association-top-10/ https://www.wholeearthgifts.com/american-kratom-association-top-10/#respond Fri, 16 Oct 2020 19:35:09 +0000 https://www.wholeearthgifts.com/?p=9231 The post American Kratom Association | Kratom Top 10 Answers appeared first on Whole Earth Gifts.

]]>

American Kratom Association Top 10

ANSWERS TO KRATOM QUESTIONS:

The AKA receives and reviews many questions about kratom and the inaccurate attacks from the FDA that deliberately distort the facts. To help combat this process, the AKA is providing a top ten list of questions and answers that refute unfair claims and pervasive misconceptions. American Kratom Association Top 10

1) Is the FDA right that kratom is an unapproved drug? American Kratom Association Top 10

No, kratom is properly classified as a food under the provisions of the U.S. Food Drug & Cosmetic Act.

The FDA regulates a product based on its intended use as evidenced by the product’s labeling and claims. The FDA does not have statutory authority to make premarket approval of food products.

When kratom products are marketed with the intent for use as a food, it is immaterial that kratom does not have any “approved uses” since food products are not approved by the FDA.

When kratom is marketed with a therapeutic claim, then it is properly subject to regulation by the FDA.

1 AKA Top 10

2) Is the FDA right that kratom is an opioid? American Kratom Association Top 10

No, kratom’s alkaloids do hit the mu-opioid receptors in the brain, but kratom is a plant from the coffee family and it does not have the same pharmacologic activity as classic opioids like heroin, morphine or fentanyl.

Kratom is properly classified as a “partial agonist” which has dramatically different effects than opioids on the brain or respiratory system.

Kratom does not give a consumer a reinforcing high that leads to addiction (consumers can become dependent on kratom, like a caffeine dependance).

Kratom does not have any significant impact on a consumer’s respiratory system – and it is “suffocation” that is the primary cause of opioid overdose deaths.
American Kratom Association Top 10

2 AKA Top 10

3) Is FDA’s claim you can you overdose on kratom true?

Consumers can harm themselves from overusing virtually any product, but research shows kratom does not cause overdose deaths like opioids do.

This question is definitively answered by the peer-reviewed published literature that specifically concluded “it appears that the risk of overdose death is >1000 times greater for opioids than for kratom.” (see https://pubmed.ncbi.nlm.nih.gov/31647958/)

The bottom line is that kratom carries little of the signature respiratory depressing effects of morphine-like opioids and kratom’s pharmacology is vastly different from opioids where most overdoses occur.

3 AKA Top 10

4) Is the FDA right that kratom is dangerously addictive?

No. The National Institutes on Drug Abuse (NIDA) funded studies to test the FDA claims that kratom should be a Schedule I drug because it poses a high potential for abuse. NIDA research shows kratom does not have a significant abuse liability.

The Hemby study (June 2018) concluded kratom does not have abuse potential and reduces morphine intake . . .” (see  https://doi.org/10.1111/adb.12639 )

The Yue study (July 2018) concluded kratom has limited abuse liability of mitragynine and potential for mitragynine treatment to specifically reduce opioid abuse. (see DOI: 10.1007/s00213-018-4974-9  )
American Kratom Association Top 10

4 AKA Top 10

5) The FDA claims more than 44 people have died from kratom. Is that true? American Kratom Association Top 10

No. An independent review of the FDA claimed deaths, and then confirmed by NIDA’s own review, found these deaths to be from polydrug use, adulterated kratom products, or an underlying health condition. The FDA’s claims are UNTRUE!

NIDA conducted its own independent review, and they came to the same conclusion.

The FDA kratom death claims are bogus, and the most egregious example is the autopsy report they tried to hide, but when disclosed, the truth was the decedent died from 2 gunshot wounds. He had also consumed a kratom tea earlier in the day. The FDA called that a ”kratom associated death.”

5 American Kratom Association Whole Earth Gifts

6) Can public health officials trust the FDA on kratom?

No. Every public policy that protects the health of the American public should be based on science, not a self-serving expansion of regulatory powers that will increase the control the FDA has over the decisions Americans make to manage their health and well-being.

In the early 1990’s the FDA made the same adverse event and death claims about vitamins and dietary supplements, and Congress was forced to step in and UNANIMOUSLY pass the Dietary Supplement Health & Education Act (DSHEA) in 1994 to reign in the FDA’s aggressive attempt to ban all dietary supplements and vitamins unless the product was submitted as a new drug application. Today, the FDA is waging the very same disinformation campaign against kratom and cannot be trusted.

6 American Kratom Association Whole Earth Gifts

7) The FDA claims kratom marketing is rampant with impermissible health claims. Is that true?

No. It is accurate that some unscrupulous vendors are making illegal therapeutic claims for kratom products. The FDA is the enforcement agency responsible for stopping that kind of advertising. The solution is for the FDA to do their job.

The vast majority of kratom products are legally marketed and labeled properly as foods. Individual consumers have the legal right to make informed choices about foods they want to consume to maintain their health and well-being. The FDA is wrong on the kratom science and wrong on the policy! American Kratom Association Top 10

7 American Kratom Association Whole Earth Gifts

8) The FDA warns that only FDA approved drugs can help in addiction recovery. Is that true? American Kratom Association Top 10

No. The FDA insists that only FDA approved drugs are the answer to addiction recovery – and those recovery centers can only use those drugs for addiction recovery if they want to be reimbursed. The Johns Hopkins report proves the FDA is wrong and their policy traps those trying to recover.

Every American family has been impacted by the opioid crisis and the FDA has remained tone deaf to the possible solution for some by using kratom. NIDA gets it, and they are the leading federal agency helping to find solutions to the opioid crisis. The FDA has made itself part of the problem by trying to ban kratom rather than protecting the public from adulterated kratom products.

8 American Kratom Association Whole Earth Gifts

9) Does the FDA influence and manipulate content of medical news articles about kratom?

Alarmingly, it appears that is exactly what is happening. An article that appeared in MedScape Medical News (an outlet for US physicians) on August 10, 2018 on the NIDA-funded Hemby study on the addiction liability of kratom had this headline:

“No Doubt Kratom Is an Opioid With High Abuse Potential”

The problem: The Hemby study found the EXACT OPPOSITE about kratom:

“The present findings indicate the MG [kratom] does not have abuse potential and reduces morphine intake . . .”

The author, Scott Hemby, told MedScape they ”misrepresented” his comments and the research and demanded MedScape ”either change the title to accurately represent the content of our findings and of my interview OR retract the story.” More than 2 years later this inaccurate article is still on the MedScape website for physicians to rely on.

MedScape published this inaccurate article at the same time they had an MOU with the FDA on information collaboration. How can anyone doubt the FDA influences and manipulates information on kratom?

9 American Kratom Association Whole Earth Gifts

10) The FDA tells medical examiners to classify any death where kratom is detected as a kratom death. That’s bad science, but great propaganda for the FDA. American Kratom Association Top 10

The FDA fuels its War on Kratom by telling medical examiners to list kratom as the cause of death whenever it is detected in the toxicology screen of a decedent. The problem is even researchers who are anti-kratom cannot point to any data showing a toxic level of kratom that would cause a death in a human. But the FDA wants them reported as kratom deaths anyway.
All fatalities the FDA report as kratom deaths actually involve polydrug use, adulterated kratom products, or underlying health conditions. Research has shown that many addicts are using kratom to try to replace highly addictive and potentially deadly drugs, so it’s not surprising that a person who overdoses or who is trying to wean off dangerous drugs, would have kratom in their system. It is time for the FDA to stop their War on Kratom.

Leading scientists in Southeast Asia reported at a NIDA conference that “There are no known reported severe toxicity or fatality incidents in Malaysia or Thailand where there are large populations of long-term daily users of kratom.”

10 American Kratom Association Whole Earth Gifts

AMERICAN KRATOM ASSOCIATION TOP 10 ANSWERS TO KRATOM QUESTIONS

 

Whole Earth Gifts

Home | Shop | Brands | Lab Tests | FAQ | Contact
Twitter | Facebook | Instagram | Youtube | Pinterest
1836 Kratom | Super Speciosa | KR8om | America Kratom Association | Kratomaton.com

The post American Kratom Association | Kratom Top 10 Answers appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/american-kratom-association-top-10/feed/ 0
Thailand cabinet okays law to control sale and use of Kratom https://www.wholeearthgifts.com/kratom-legality-cabinet-okays-law-to-control-sale-and-use-of-kratom/ https://www.wholeearthgifts.com/kratom-legality-cabinet-okays-law-to-control-sale-and-use-of-kratom/#respond Tue, 13 Oct 2020 13:20:36 +0000 https://www.wholeearthgifts.com/?p=9411 The post Thailand cabinet okays law to control sale and use of Kratom appeared first on Whole Earth Gifts.

]]>

Kratom Legality

Cabinet okays law to control sale and use of Kratom

nationthailand.com | Oct 13. 2020 | The Nation

The draft Narcotics Act proposed by the Ministry of Justice to control the use of kratom (mitragyna speciosa)
was approved by the Cabinet meeting on Monday, Government deputy spokeswoman Ratchada Thanadirek said.

On March 10, the Cabinet had approved the removal of kratom from Thailand’s narcotics list.

“The draft aims to control the use of kratom and prevent children and adolescents from abusing it,” she said. “The rules to be enforced are as follows: Kratom Legality

▪︎ The manufacture, import and export of kratom are only allowed by those who have permission from the Office of the Narcotics Control Board. Violators will be punished with a maximum Bt200,000 fine and maximum two years’ imprisonment.
▪︎ Selling of kratom to persons under 18 years old or pregnant women is prohibited, as well as hiring or allowing persons under 18 years to sell kratom, with punishment at a maximum of Bt200,000 fine and maximum two years’ imprisonment.
▪︎ Selling of kratom in schools, dormitories, public parks, theme parks, or via online channels is prohibited and punishable with a maximum Bt40,000 fine.
▪︎ Any form of advertising or marketing communication of kratom is prohibited and punishable with a maximum Bt500,000 fine and a maximum of six months’ imprisonment.
▪︎ Persons under 18 years old are prohibited from taking kratom either in pure form or mixed with other drugs.Kratom Legal

ity
Encouraging persons under 18 years old or pregnant women to take kratom is also prohibited and is punishable with a maximum Bt2,000 fine.
This law excludes the use of kratom as an ingredient in herbal, medical, food, and cosmetic products. Kratom Legality
The Cabinet will later forward the draft to the Council of State who will review it after which it will be submitted to Parliament for voting.
If the draft is passed, Thailand will be among 37 countries such as Japan, Serbia, Croatia, and Syria, who use a specific law to control the consumption of kratom and not a narcotic law.

Kratom Legality

Whole Earth Gifts

Home | Shop | Brands | Lab Tests | FAQ | Contact
Twitter | Facebook | Instagram | Youtube | Pinterest
1836 Kratom | Super Speciosa | KR8om | America Kratom Association | Kratomaton.com

Kratom Legality

Kratom Legality

The post Thailand cabinet okays law to control sale and use of Kratom appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/kratom-legality-cabinet-okays-law-to-control-sale-and-use-of-kratom/feed/ 0
Kratom: The Bitter Plant That Could Help Opioid Addicts, if the DEA Doesn’t Ban It | Simon and Nick Stockton | Wired.com | 11.30.16 https://www.wholeearthgifts.com/kratom-could-help-addicts/ https://www.wholeearthgifts.com/kratom-could-help-addicts/#respond Fri, 09 Oct 2020 17:52:31 +0000 https://wholeearthgifts.com/?p=3461 The post Kratom: The Bitter Plant That Could Help Opioid Addicts, if the DEA Doesn’t Ban It | Simon and Nick Stockton | Wired.com | 11.30.16 appeared first on Whole Earth Gifts.

]]>

Kratom could help addicts

Kratom: The Bitter Plant That Could Help Addicts—if the DEA Doesn’t Ban It

Kratom could help addicts
ARIANA CAMPELLONE GREW 
up in East Greenwich, Rhode Island. It is a small community, affluent and charmingly New England. Heroin was very available there, and very good.By age 15, Campellone was a daily user. She stopped going to school, stopped doing much of anything besides scoring drugs, doing drugs, stealing stuff, selling stuff, scoring more drugs, doing more drugs. “This was the beginning of the New England heroin epidemic,” she says. “Everyone I knew was overdosing, dying, lives falling apart, people contracting diseases from sharing needles.”

That experience was mirrored around the country. In 2014, overdoses from heroin or prescription opioids killed 30,000 people—four times as many than in 1999. Today, 3,900 new people start using prescription opioids for non-medical purposes every day. Almost 600 start taking heroin. The yearly health and social costs of the prescription opioid crisis in America? $55 billion.

Campellone kicked her habit at 19—with rehab, suboxone, and a lot of willpower—and moved out west, to the San Francisco Bay Area. She began working at a natural remedy shop in Berkeley. Her bosses and co-workers introduced her to a plethora of plant-based products, among them a tart-tasting leaf called kratom. It gives a slight, euphoric high. Like the feeling that remains when you spin around in circles, after the dizziness wears off. It was also a decent painkiller, so she’d take it when she was hurt, or on her menstrual cycle.

And, on two occasions, she used it to help with the withdrawal symptoms following heroin relapses. “Nothing really feels good when you’re withdrawing from heroin, so no matter what you’re taking, you’re still in pain and it’s pretty excruciating,” says Campellone. But kratom helped some.

Campellone never needs a prescription to get kratom. Nor does she have to visit a dealer. She buys it from an herbal remedy store—about $20 for a 4 ounce packet, which lasts about a week. When she takes too much, she gets a stomach ache. And when she does not take it, she doesn’t crave it like she craved heroin. Mostly she doesn’t think about it; it just sits in her cabinet. So, she was surprised when, on August 30, the DEA announced that it was pursuing an emergency scheduling of mitragynine and 7-hydroxymitragynine, the active alkaloids in kratom. Campellone was one of perhaps 4 or 5 million Americans who were being told, for maybe the first time, that this leaf posed an “imminent danger to public safety.”

The DEA Takes an Exception to Kratom Kratom could help addicts

Biologically, kratom acts enough like an opioid that DEA considers it a threat to public safety. The agency planned to use a regulatory mechanism called emergency scheduling to place it in the same restrictive category as heroin, LSD, and cannabis. This category, Schedule I, is reserved for what the DEA considers the most dangerous drugs—those with no redeeming medical value, and a high potential for abuse.

Kratom leaf

GETTY IMAGES

Before they finalized the scheduling, something surprising happened. An advocacy group called the American Kratom Association (yes, AKA) raised $400,000 from its impassioned membership—impressive for a nonprofit that typically raises $80,000 a year—to pay for lawyers and lobbyists, who got Congress on their side.

On September 30, representatives both conservative and liberal—from Orrin Hatch to Bernie Sanders—penned a letter to the DEA. “Given the long reported history of kratom use, coupled with the public’s sentiment that it is a safe alternative to prescription opioids, we believe using the regular review process would provide for a much-needed discussion among all stakeholders,” they wrote.

It worked. The DEA lifted the notice of emergency scheduling, and opened a public comment period until December 1. When was the last time the DEA backed off anything? “This is unusual,” says Gantt Galloway, a Bay Area pharmacologist specializing in treatments for addictive drugs. Galloway could not recall another instance when the DEA responded to public outcry like this.

As of this writing, those comments number nearly 11,000. They are from: people who use kratom to relieve chronic pain or endometriosis or gout; people who use kratom to treat depression or wean off opioids or alcohol; people who said it saved their life. “It doesn’t allow you to escape your problems,” says Susan Ash, founder of the AKA, who used kratom to treat pain and escape an addiction to prescription opioids. “It instead has you face them full on because it doesn’t numb your brain at all, and it doesn’t make you feel stoned like medical marijuana does. And yet it’s effective on so many things, like pain and anxiety and depression.”

Kratom could help addicts

That promise is part of the problem. Scientists know practically nothing about kratom—how its compounds work in concert, what it can actually treat, how addictive it might be, what counts as a safe dose. And certainly not enough to back up all the life-changing claims extolled in public comments, and by the many kratom users we interviewed. In the absence of good science and the slightest hint of regulation, Ash and potentially millions of other users are winging it. And should the DEA follow through on its promise to schedule kratom, these people will become criminals overnight.

For Ash, that’s completely unacceptable. “I want the future to look like this is your next coffee,” she says. “I’d like it to be sold in Starbucks. I’m not even kidding.”

An Herb Wades Into an Opioid Crisis Kratom could help addicts

Kratom is not an opioid—actually, it is in the coffee family—but its active molecules bind to the same neuronal receptors as opioids like heroin, codeine, oxycodone, and morphine. Typically, those drugs give users a feeling of euphoria and dull their pain—that’s why David*, a former boarding school teacher, started using prescription opioids to treat his discomfort from ski injuries. He became addicted, and when his prescriptions ran out, he switched to heroin. “I became a high functioning user,” he says. “My addiction was never detected at my place of employment, although I do think my behavior became more erratic.”

When David eventually committed himself to rehab, his doctors weaned him off heroin using suboxone, a combination of two drugs—buprenorphine, a partial opioid that quenches the body’s chemical thirst, and naltrexone, which blocks any euphoric opioid feelings. But suboxone can give users symptoms of withdrawal, not to mention a dulled sense of reality. And users like David can still find ways to abuse it. “Dependence on that was different from heroin, and it became easier to take more suboxone to a higher high, or selling it to score heroin again,” he says.

As of this writing, though, David has been clean for 18 months—success that he attributes to kratom. Since it binds to the same receptors as opioids, kratom users report similar euphoric and pain-killing effects, but they’re muted. After other 12 step recovering addicts introduced David to the plant, it helped him rebuild his life—he did eventually lose that boarding school teaching job—and deal with the physical pain that got him hooked on opioids to begin with.

Since it mirrors opioids in other ways, the concern is that kratom is also addictive. But again, the real science is sparse. David and several other users we spoke with said kratom is habit forming, to some degree, though one survey in Southeast Asia found that for people using it to kick an opioid addiction, the dependence is far less likely to disrupt their lives. “When I take kratom, that addictive part of me kicks in and it becomes habitual,” says Jeffrey*, another former opioid addict. “It doesn’t throw my life out of control, but it bugs me when people say things like, ‘it’s not more addictive than coffee.’ I think that hinders us making inroads with the regulators.”

Kratom could help addicts

There is no doubt, however, that kratom is less harmful than opioids—even take-home synthetics like suboxone. When opioids kill, they do it through respiratory depression—they slow your breath until you stop breathing entirely. But kratom’s chemical composition doesn’t appear to produce the same effects. “The two main alkaloids in kratom, mitragynine and 7-hydroxy, appear to have a low ceiling for respiratory depression,” says pharmacologist Jack Henningfield of the Johns Hopkins School of Medicine, who with the consulting firm Pinney Associates has advised the AKA on kratom scheduling. “And that’s why if you look hard, it’s very difficult to find deaths attributable purely to kratom.”

Notice he said “purely.” In its initial notice of emergency scheduling for kratom, the DEA did link the drug to 15 deaths between 2014 and 2016. But that accounting ignores the fact that all but one of those people had other substances in their systems. Folks using kratom to wean themselves off opioids may still be taking those opioids.

And some deaths could be attributed to contamination: Because kratom isn’t strictly regulated, bad actors can and do lace the plant with actual opioids, like the extremely powerful synthetic opioid fentanyl. “You can just imagine, ‘Oh you got pain? Well, we’ve got a special kratom product,’” Henningfield says. “Maybe it has fentanyl in it. That’s scary.” Clearly, the plant needs some kind of regulation. The question is whether the DEA’s scheduling is the right kind.

Regulatory Wranglings Kratom could help addicts

The FDA could help prevent contamination-related deaths by strictly regulating kratom as a supplement, as opposed to the DEA scheduling it as a drug. “FDA has a lot of authority to actually help consumers know that what they’re buying is what is labeled, and have at least some level of assurance,” Henningfield says. “It’s not close to the drug standard, but it’s much better than something that’s illicitly marketed.”

Kratom could help addicts

But the FDA is actually also pivotal in advising the DEA on the scheduling of drugs. “The decision to permanently schedule any drug is not a DEA unilateral decision,” says Steve Bell, a DEA spokesperson. Consider the regulatory pathway of suboxone. The FDA approved the drug in 2002, and the Department of Health and Human Services recommended that the DEA put it in Schedule III, which the DEA accepted. This puts the drug in the same category as Tylenol with codeine: It’s available for doctors to prescribe for narcotic addiction, but is still a controlled substance.

Schedule I, though, is an entirely different rodeo. If the DEA places kratom here, nobody can touch the stuff. Current users, should they continue to use, will be forced to even sketchier sources. And scientists will have a harder time learning how kratom works, and supporting, or refuting, the claims users make with hard data. (Consider marijuana, also a Schedule I drug. Science has a dearth of data on it because getting permits to study the drug is an exercise in bureaucratic insanity.)

All that research costs money. Which is kratom’s catch-22: The DEA wants to schedule the drug because they think it might pose a danger to public health, but the only way to confirm (or refute) the DEA’s worries is with more research—which will be next to impossible should the DEA follow through on its promise to schedule.

One of the few scientists studying kratom is the University of Florida’s Oliver Grundmann, who is finishing up an online survey of nearly 10,000 users. And the data (preliminary, though Grundmann plans to publish a paper in the coming months) reveals a different profile of kratom users than you’d expect from an “illicit” recreational drug.

“The age range is more geared toward an older population,” says Grundmann, “which is more likely to experience work related injuries or acute or chronic pain from another medical condition.” Over half of users are between the ages of 31 and 50. Eighty-two percent completed at least some college. Nearly 30 percent of respondents pull in a household income of over $75,000 a year. Not quite the party drug demographic. And the public comments on the DEA’s scheduling notice reflect that population. Many of those folks are using kratom to either wean themselves off prescription opioids or use the drug alone to treat pain.

Still, that’s self-medication using a product that may be contaminated. “The industry needs to come together,” says Susan Ash of the AKA. “There’s no way the FDA is going to feel comfortable not seeing this as a scheduled controlled substance without a commitment from the industry that there will be proper measures put in place.” Better labeling, for instance, would be a start.

Kratom could help addicts

Grundmann says he understands the DEA’s motivation. “They do not want to have another drug out there that could potentially contribute to the already devastating opioid epidemic that some communities are experiencing,” he says. “But on the other side, we also need to consider that the 4 to 5 million estimated users of kratom may face a health crisis of their own if kratom becomes scheduled.”

Anecdotes and Evidence

Ariana Campellone takes her kratom with coconut milk and protein powder. Then, she mixes, diluting with water to take the lumps out of the mixture. By itself, the stuff tastes awful. Like oversteeped tea, or a mouthful of peat. She thinks the comparison to coffee is a bit overstated. “Coffee gives me a noticeable spike and high, and can feel when I’m coming down,” she says.

The DEA’s public comment period closes tomorrow. The agency says it will consider those comments alongside the FDA’s scientific and medical evaluation before proceeding to schedule. The FDA did not respond in time to comment on this story.

However, if the DEA follows through on its previous intent to schedule, Campellone says she’ll still continue to use kratom. “Just like people have continued to use cannabis where it’s not legal,” she says. In practical terms, it means getting ahold of kratom would probably get more expensive and personally risky. Those costs, those risks—those hassles—might not be worth it to some kratom users. And then the not-so-small community of recovering opioid addicts lose something available, and possibly quite good.

*This name has been changed to protect anonymity.

 

The post Kratom: The Bitter Plant That Could Help Opioid Addicts, if the DEA Doesn’t Ban It | Simon and Nick Stockton | Wired.com | 11.30.16 appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/kratom-could-help-addicts/feed/ 0
Release the Kratom | Emma Grey Ellis | Wired.com | 1.22.20 https://www.wholeearthgifts.com/kratom-to-quit-opioids/ https://www.wholeearthgifts.com/kratom-to-quit-opioids/#respond Tue, 06 Oct 2020 16:01:26 +0000 https://wholeearthgifts.com/?p=3414 The post Release the Kratom | Emma Grey Ellis | Wired.com | 1.22.20 appeared first on Whole Earth Gifts.

]]>

Release the Kratom: Inside America’s Hottest New Drug Culture

01.22.2020 07:00 AM | Wired.com

Leaves of a kratom plant
Just about the only thing everyone agrees on is that kratom is a plant, a tropical evergreen tree that grows wild in Thailand, Malaysia, Indonesia, Myanmar, and Papua New Guinea.PHOTOGRAPH: GETTY IMAGES

BY HER MID-20S, Faith Day was out of jail but homeless. She was also addicted to a substance now too legally compromising to name. When she tried to quit, she couldn’t afford the medication to manage the withdrawal symptoms. She looked to the internet for answers. News about a plant called kratom kept popping up in her social media feeds, alongside claims that consuming it would help her break free of addiction. Many use kratom to quit opioids. Desperate, she used her last $140—money that would have otherwise gone to the destructive drug—on an ounce she found at a head shop.

Two weeks later, she was off the drug. She has not relapsed since. Now, Day devotes her life and career to kratom. She’s no back-alley pusher—her goal is get kratom out of head shops, gas stations, and dark street corners and into the safe, legal light of day.

By some scientists’ count, there are between 10 million and 15 million kratom users in the US alone. They are using the drug for everything from chronic pain relief to replacement for their morning coffee. It is not an illicit substance; unless you live in one of the six states where kratom possession is criminalized, or are part of the US Army or Navy, which also banned the drug, kratom capsules, extracts, and teas are legal to buy and sell. However, after finding kratom in the systems of dozens of people who have died of drug overdoses, the federal government has been considering a total ban. It warns consumers of potential opioid-like effects, though scientists have questioned the FDA’s methodology in coming to that conclusion. Some people, like Day, will tell you kratom saved their lives. Others ask her if she’s selling “legal heroin.”

Day’s is one of only two kratom businesses licensed by the Department of Agriculture in the entire country. If you ignored the sign, her Oregon storefront, Clean Kratom Portland, could be a coffee shop or a trendy marijuana dispensary. The air is sweet and spicy with incense, the walls bright white and pale green, the plants plentiful, the bar wood, and the binders of lab tests numerous. Day greeted me at the door, along with a giant, exuberant husky named Max. She is wearing a long cardigan and a careful smile. Every visible expanse of skin is tattooed—hands, chest, neck, face. As they travel upward, the tattoos turn from birds and dots to the structural formulas of chemical compounds found in kratom. The arc of hexagons above her left eyebrow is speciogynine, thought to be a smooth muscle relaxer. She credits it with stopping awful withdrawal convulsions.

Day started her kratom business in Denver, and she’s in Portland for one reason only: Google Trends. Of all the people in the US, it’s Portlanders who search for kratom the most per capita. It’s hard to say why that might be—the reasons people give for using kratom vary widely. It’s equally fruitless to try to stereotype an average American kratom user. Many use kratom to quit opioids. Many are trying to quit opioids or alcohol. Others are trying to manage chronic pain, improve their eyesight, clear up their skin, boost their immune systems, or just have fun and get high. “A third of our clientele are looking for a caffeine-free alternative to get them through their day,” Day says. “I’m talking soccer moms.”

The image of wealthy moms slurping kratom tea in lieu of a cappuccino, or trendy Bay Area residents popping kratom pills socially just for its mild, mellow body high, cuts strangely against the dire tone of most government reports on kratom. The US Food and Drug Administration warns consumers to avoid kratom, noting that it appears to affect “the same opioid brain receptors as morphine” and may come with the same risks of dependence. The CDC has reported 91 kratom-involved overdose deaths and found the drug in the systems of 61 other overdose deaths.

There was a reason kratom was so present in Day’s social feeds in 2016: The DEA had just stated its intent to ban kratom and reclassify it as Schedule 1 drug. Then it reversed the decision following prolonged outcry from the public and the scientific community. “I don’t think that’s ever happened before,” says Marc Swogger, who studies the therapeutic use of drugs at the University of Rochester Medical Center. “I think they didn’t do any research about how many people were using this plant and what they were using it for, and they were surprised at the response.” Day is never surprised when people are surprised by kratom. The plant is surrounded by so much misinformation that it’s often hard to separate fact from flackery or fearmongering.

Just about the only thing everyone agrees on is that kratom is a plant, a tropical evergreen tree that grows wild in Malaysia, Thailand, Indonesia, Myanmar, and Papua New Guinea. It’s a relative of the coffee tree. Within its native range, it’s been used for centuries (at least) as an herbal remedy, especially among day laborers who would chew the leaves for a mild stimulant effect. At the end of a hard day’s work, people might then brew the leaves into a tea, extracting different compounds purported to have a calming and pain-relieving effect.

Many use kratom to quit opioids.

It’s still used that way in Southeast Asia. According to Darshan Singh, a researcher at the University of Science, Malaysia’s Center for Drug Research, contemporary Malaysian kratom users fall into four categories: old folks practicing traditional medicine, manual laborers, people trying to get off opioids, and people who use kratom in lieu of other illicit drugs, sometimes mixed with cough syrup. (He notes that all categories do tend to share a gender. “Due to societal discrimation,” he says, “kratom use among females is not widespread.”) So far, there have been no kratom-linked deaths in Malaysia, despite its long history and ubiquity. “It is seen that kratom use has become [more of] a major issue in the US than in its local context in Southeast Asia,” Singh says. In Thailand, kratom is on the brink of total legalization.

Southeast Asia is a long way from Portland, and it took kratom a long while to get there. Kratom was described by a Dutch colonial botanist in 1839, but according to Oliver Grundmann, who studies the effects of herbal products on the central nervous system at the University of Florida, interest in the US and Europe didn’t become widespread until the mid-2000s and 2010s. (Though it’s difficult to draw causal links, that does roughly correlate to the rise of the opioid epidemic.)

Most of what Grundmann knows about today’s American kratom use has come from online surveys. He acknowledges that there are biases inherent in that kind of self-reported study, but outside of head shops and Portland convenience stores declaring “Kratom Sold Here,” online is where kratom culture lives. It’s where Day sold her products when she first got started. Many use kratom to quit opioids. It was also the scene of the drug’s largest scandal. Last year, a seller in Michigan was forced to forfeit $1 million he’d made hawking kratom online because he was claiming it cured medical conditions like Lyme disease. Facebook is home to dozens of dedicated kratom groups; there are multiple kratom subreddits. Kratom supplements, much like CBD, have become a frequently promoted product in the Instagram economy, especially among fitness influencers claiming it helps with recovery after tough workouts. Once you scroll past a few scary articles from the DEA, FDA, and the Mayo Clinic, kratom’s online presence is somewhat chic.

With digitization comes anonymity. Even after careful study, neither Grundmann nor Swogger are able to generalize about who in America is taking kratom. In 2016, after conducting an online survey of over 8,000 people in the US, Grundmann found few trends in age, income, or gender—kratom cuts straight through the middle of society. He did find that about two-thirds of kratom users were using the drug to treat chronic and acute pain or mental and emotional disorders like anxiety and depression. Only a minority were using it to mitigate withdrawal symptoms or using it recreationally, and recreational users tended to prefer other illicit drugs over kratom—the plant gets you high, but not that high.

So, are these some 15 million Americans using the opioid-adjacent killer the DEA fears? Grundmann sees the fact that a highly purified, injectable form of kratom does not exist as evidence that the DEA may have overstated its similarity to opiates: “If kratom were really so powerful, why don’t we see anything like that, despite having a sophisticated underground machinery that could easily come up with extraction techniques if they wanted to?” Grundmann says. “Instead, we see fentanyl and its derivatives contributing to the opioid crisis.” Swogger concurs, as do many other scientists. The compounds in kratom require a great deal of further study to determine what exact effects they do have, but while some bind to the same chemical receptors as opioids, they do so quite differently. Kratom is triggering the same part of your brain’s reward system, but in a way that is (perhaps, hypothetically) less addictive. “When millions of people say they’re using kratom, and it’s helping them with conditions that are really difficult to help people with, we have to listen,” Swogger says. “I’m not convinced that a single death has been the result of kratom.”

A person takes notes next to a pile of plastic bags filled with kratom leaves.
By some scientists’ count, there are between 10 million and 15 million kratom users in the US alone.PHOTOGRAPH: DIMAS ARDIAN/BLOOMBERG/GETTY IMAGES

Thing is, people are dying, and that’s not even the only reason to take issue with kratom’s rising trendiness. The likeliest reason for the fatalities, Day thinks, is less kratom than the substances being used to adulterate it. Shortly after she started posting about her own experiences with kratom online, a man who ran a head shop in Colorado began messaging her, and they became romantically involved. “It turned out to be a bad situation,” she says. “I got trapped inside of an apartment for six months and didn’t have anything else to do but work with him and watch this person making assloads of money selling kratom in a really inappropriate manner.”

Some sellers add just about anything to kratom: potato starch, matcha, flour. Others don’t pay much attention to what’s already in it. Day has seen kratom sold clumpy with mold and dirt. “Someone died using at his store,” Day says of her ex. “So, out of this traumatic experience, I realized I didn’t want to be homeless anymore and maybe I could make a business for myself doing this the right way.” She called labs every day until they started testing kratom for contaminates. Today, she takes pride in offering customers evidence that her products are tested. This has also earned her many enemies. Just because kratom culture is stretching toward the mainstream doesn’t mean it can’t also get nasty when someone threatens the status quo: “I’ve been very vocal that I think kratom should be regulated like marijuana,” Day says. “So much so that … I’ve gotten death threats from kratom users online. Many use kratom to quit opioids. There’s a lot of wild stuff on the internet. I try not to focus on it.”

Many use kratom to quit opioids.

Even if there aren’t contaminants in the kratom you’re ingesting, the manner in which it’s sold presents other dangers. That guy who got busted for claiming that kratom cured Lyme disease? He’s not alone. “We’ve done mystery shopping, and some of the interactions I’ve had are just insane. I wanted to jump across the counter,” Day recalls. “One guy said it will get you high like morphine. Another said it would cure cancer.” To be clear, it doesn’t. Some preliminary studies have suggested certain compounds found in kratom might have possible anticancer effects. Even if that’s true, at this point it’d be a bit like saying blueberries cure cancer because they’re high in antioxidants.

Like many high-value crops (especially semi-illicit ones), the kratom industry is also built on frequently exploitative labor practices, mostly in remote, rural areas in Indonesia. According to Day, who imports her kratom from the country, Indonesia’s drug enforcement agency, the BNN, has been under pressure from the US to ban kratom production by 2022, imperiling the kratom farmers’ livelihoods.

So the DEA and FDA’s worries aren’t unwarranted. “They are rightly concerned about any substance that they have very little control over that patients and consumers are using to self-treat medical conditions,” the University of Florida’s Grundmann says. “When you talk about withdrawal, depression, anxiety—that usually belongs in the hands of a medical professional.” Few seem to think that calls for a ban, though. “If we completely cut off any legal way for those consumers to get kratom, then we don’t have any oversight left.”

Many use kratom to quit opioids.

Instead, it might be more helpful to consider what kratom’s widespread use says about where our culture around drugs and medicine is now. “Many kratom users I’ve talked to don’t feel comfortable interacting with doctors, which is to their detriment,” the University of Rochester’s Swogger says. “But we can’t pretend like the medicines we’re providing are getting to everyone. They’re not.” While not everyone who takes a kratom supplement has a story as dramatic as Day’s—from homeless substance abuser to business owner and mother—it’s clearly filling a need for millions of people. The need to regulate, but not ban, kratom use is already being acknowledged on the state level: The Kratom Consumer Protection Act has been passed in Arizona, Georgia, and Utah, and is pending in Oregon.

“If it was as dangerous as the media says, I don’t think that would be happening. Nobody’s passing a heroin consumer protection bill,” Day adds. “It’s just weird.” You probably know how Portland feels about weird. The place plans on keeping it.


 

Whole Earth Gifts

Home | Shop | Brands | Lab Tests | FAQ | Contact
Twitter | Facebook | Instagram | Youtube | Pinterest
1836 Kratom | Super Speciosa | KR8om | America Kratom Association | Kratomaton.com

The post Release the Kratom | Emma Grey Ellis | Wired.com | 1.22.20 appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/kratom-to-quit-opioids/feed/ 0
Feds Incinerate 28 Tons of Kratom | Pat Anson | PNN | 2.12.20 https://www.wholeearthgifts.com/federal-government-destroys-kratom/ https://www.wholeearthgifts.com/federal-government-destroys-kratom/#respond Sun, 04 Oct 2020 17:44:00 +0000 https://wholeearthgifts.com/?p=3457 The post Feds Incinerate 28 Tons of Kratom | Pat Anson | PNN | 2.12.20 appeared first on Whole Earth Gifts.

]]>

Federal Government Destroys Kratom

Feds Incinerate 28 Tons of Kratom

 Pat Anson, PNN

Over 28 tons of the herbal supplement kratom were recently destroyed by the federal government, the final chapter in a legal battle over one of the largest seizures of kratom in U.S. history. The federal government destroys kratom.

The U.S. Marshals Office paid a hazardous waste company nearly $30,000 to transport the kratom from South Carolina to Florida, where it was incinerated at an energy-from-waste facility. The kratom had an estimated value of $1 million.

Kratom is a dietary supplement that millions of Americans use to self-treat their chronic pain, anxiety, depression and addiction.  It comes from the leaves of a tree that grows in southeast Asia, where kratom has been used for centuries as a natural stimulant and pain reliever.

Federal Government Destroys Kratom

The incinerated kratom was seized in 2018 after FDA inspectors found large quantities of kratom powder and capsules at a warehouse in Myrtle Beach, SC operated by Earth Kratom, a kratom wholesaler and vendor.

At the time, the federal government was engaged in a public relations campaign against kratom, led by then-FDA Commissioner Scott Gottlieb. Federal officials claimed kratom was a risky and addictive substance that should not be used to treat any medical condition.

Federal Government Destroys Kratom

“Serious concerns exist regarding the effect of kratom on multiple organ systems. Consumption of kratom can lead to a number of health impacts, including respiratory depression, vomiting, nervousness, weight loss, and constipation. Kratom consumption has been linked to neurologic, analgesic and sedative effects, addiction, and hepatic toxicity,” U.S. Attorneys said in a civil forfeiture complaint that led to the kratom being seized.

Kratom can be sold legally in South Carolina and most U.S. states, but vendors can run into trouble if they claim it can be used to treat medical conditions.

“There’s nothing wrong with our facilities or our product,” explained Brian Stall, supervising manager for Earth Kratom. “We were selling a product for human consumption and they didn’t like that.”

Stall told PNN that Earth Kratom’s lawyers were able to persuade a judge to order the kratom returned, but it was seized a second time by U.S. Marshals. The kratom was wrapped in plastic and remained at Earth Kratom’s warehouse, but was off-limits to the company.

Federal Government Destroys Kratom

“They took all of our product and half of our building at that point,” said Stall. “It was a tough time for us. We’d worked really hard and really believed in the product. It really sucked.”

Earth Kratom’s entire inventory may have gone up in smoke, but it survived the ordeal and remains in business. It sells one of the most popular kratom brands, Trainwreck Kratom, a blend that combines several different kratom strains. PNN’s Crystal Lindell raved about Trainwreck as a pain reliever in a 2018 column.

Federal Government Destroys Kratom

Scott Gottlieb resigned as FDA commissioner in March 2019 and weeks later joined the board of directors at Pfizer. Although the FDA’s campaign against kratom seems to have quieted since Gottlieb’s departure, an import alert remains in effect that allows FDA inspectors to seize kratom products even “without physical examination.”

A recent study funded by the National Institute on Drug Abuse concluded that kratom is an effective treatment for pain, helps users reduce their use of opioids, and has a low risk of adverse effects.

 

Whole Earth Gifts

Home | Shop | Brands | Lab Tests | FAQ | Contact
Twitter | Facebook | Instagram | Youtube | Pinterest
1836 Kratom | Super Speciosa | KR8om | America Kratom Association | Kratomaton.com

The post Feds Incinerate 28 Tons of Kratom | Pat Anson | PNN | 2.12.20 appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/federal-government-destroys-kratom/feed/ 0
What is Kratom? | Jacqueline Stenson | nbcnews.com | 10.16.19 https://www.wholeearthgifts.com/what-is-kratom/ https://www.wholeearthgifts.com/what-is-kratom/#respond Thu, 01 Oct 2020 17:38:00 +0000 https://wholeearthgifts.com/?p=3454 The post What is Kratom? | Jacqueline Stenson | nbcnews.com | 10.16.19 appeared first on Whole Earth Gifts.

]]>

What is kratom? The popular herbal supplement has caught flak from the FDA

Oct. 16, 2019, 3:31 AM CDT

By Jacqueline Stenson | nbcnews.com
Follow NBC HEALTH on Twitter & Facebook.

What is kratom? Some advocates credit the supplement with getting them off opioids.

Whole Earth Gifts What is Kratom? wholeearthgifts.com

Whole Earth Gifts What is Kratom?

The herbal supplement has surged in popularity, prompting pushback from the FDA. Chelsea Stahl / NBC News; Getty Images

Bobby DiBernardo credits the herbal supplement with getting him off heroin, oxycodone and alcohol six years ago.

“It saved my life,” he said. “I could have died any day from a heroin overdose and kratom gave me a new lease. It helped take away the pain of withdrawal.”

DiBernardo, 41, of Rochester, New York, still mixes a teaspoon of the herbal powder into a glass of water once or twice a day and drinks it even though he says it tastes terrible.

He is just one of the millions of Americans — potentially upwards of 15 million, according to estimates from the American Kratom Association (AKA) — to use kratom, a supplement made from the leaves of the Mitragyna speciosa tree native to Southeast Asia. Since at least the 19th century, the leaves have been either chewed or brewed in tea by people in Thailand, Malaysia and Indonesia to relieve pain, ease fatigue and boost mood. Kratom is believed to act like a stimulant at lower doses and have opioid-like painkilling effects and sedative properties at higher doses.

But as the supplement has surged in popularity in the U.S., safety concerns have prompted the Food and Drug Administration to warn consumers against kratom use and to crack down on companies making fraudulent health claims.

“We have issued numerous warnings about the serious risks associated with the use of kratom, including warnings about the contamination of products with high rates of salmonella that put people using kratom products at risk, and resulted in numerous illnesses and recalls,” acting FDA Commissioner Dr. Ned Sharpless said in a June 2019 statement, when the agency issued warning letters to two companies selling kratom. “Despite our warnings, companies continue to sell this dangerous product and make deceptive medical claims that are not backed by science or any reliable scientific evidence.

Six states — Alabama, Arkansas, Indiana, Rhode Island, Vermont and Wisconsin — and the District of Columbia have even taken the step of banning the supplement.

That’s a move that advocates, including Lois Gilpin, 58, of Louisville, Kentucky, oppose.

Gilpin has been mixing powder into her orange juice about two or three times a day for four years and says it relieves the chronic pain in her left leg and back so well that she can now get out of bed and enjoy her family again. “It’s definitely not a fix-all,” Gilpin said. “But for it to work well enough that I’m able to pick up my granddaughters from school and take them to the park is huge.

She was so impressed with kratom that she began volunteering her time to coordinate the social media efforts of the AKA, a consumer advocacy group in Virginia that was founded in 2014.

So, is kratom really all it’s cracked up to be? Or is more caution needed?

How is kratom being used in the United States?

A 2016 online survey of more than 8,000 kratom users contacted primarily through the AKA found that most were using the product for relieving pain or treating mood disorders such as depression and anxiety. Others used kratom to combat withdrawal symptoms from prescription opioid or illicit drug use.

Most often, kratom was consumed as a powder mixed into a drink or in pill form, according to the survey, which was conducted by Oliver Grundmann, a clinical associate professor of medicinal chemistry at the University of Florida, and published in the journal Drug and Alcohol Dependence.

Is there solid evidence that kratom is beneficial?

“To date, we don’t really have clinical studies, rigorous studies like we do for drugs that the FDA requires before a drug is approved to enter the market,” Grundmann said.

That rigorous “gold standard” is not required before dietary supplements can be sold; instead, “what we have primarily are the beneficial uses that have been reported in a traditional setting in East Asia, and surveys and user reports in the U.S. and Europe,” he said.

In his survey, the most commonly reported benefits of kratom were reduced pain, increased energy and better mood. The majority of respondents reported benefit at doses up to five grams taken up to three times per day.

Kratom often comes in a powdered form.Mary Esch / AP file

“I would say that we have relatively good anecdotal emerging evidence that kratom has benefits for the average user as long as we consider how much kratom is being used and what products are being used,” Grundmann said.

But while there may be encouraging anecdotal reports of benefits, some experts are calling for more research.

 

Is kratom safe?

That depends on whom you ask — and opinions vary widely.

The FDA has issued a strong warning against kratom use. “FDA is concerned that kratom, which affects the same opioid brain receptors as morphine, appears to have properties that expose users to the risks of addiction, abuse and dependence,” the group states.

Kratom is an opioid. #FDA continues to be deeply concerned that it’s widespread recreational use is contributing to the opioid addiction crisis. People are abusing kratom and, in some cases, are unaware that they’re using an opioid with addictive qualities https://t.co/8XeD44DiPQ

— Scott Gottlieb, M.D. (@SGottliebFDA) February 25, 2019

“There are no FDA-approved uses for kratom, and the agency has received concerning reports about the safety of kratom,” the FDA says in a statement. “FDA is actively evaluating all available scientific information on this issue and continues to warn consumers not to use any products labeled as containing the botanical substance kratom or its psychoactive compounds, mitragynine and 7-hydroxymitragynine.”

In fact, in 2016, the Drug Enforcement Administration went as far as temporarily listing kratom as a Schedule 1 controlled substance — a classification that means it has no accepted medical use and high potential for abuse — only withdrawing the decision after a public outcry and a targeted petition effort from advocates.

The FDA also has expressed concerns that kratom products may be contaminated with heavy metals or salmonella, and that marketers are making misleading health claims.

In 2018, for example, the supplement was linked to a multistate outbreak of salmonella, prompting a mandatory recall by the FDA. (A specific source of that contamination was not identified, however, it may have occurred during the growing or manufacturing process.) And an April 2019 analysis of 30 different kratom products found traces of heavy metals, including lead.

Over the summer, the FDA issued warning letters to two companies for selling “unapproved, misbranded kratom-containing drug products with unproven claims about their ability to treat or cure opioid addiction and withdrawal symptoms.”

It’s that illusion that it is a plant so it’s going to be OK.

Dr. Paul Earley, an addiction medicine specialist in Atlanta and president of the American Society of Addiction Medicine, said that he treats patients dependent on kratom, including a recent patient who was in recovery from opioid abuse when he switched to kratom thinking it was safe. That patient later had to be hospitalized for kratom dependence.

“It’s that illusion that it is a plant, so it’s going to be OK, it’s milder than heroin — and yes that’s true — but it’s not a safe compound,” Earley told NBC News.

“Kratom does produce a physical dependence, and people who are susceptible to addiction especially should stay away from it, because it’s going to tickle that same part of the brain that opioids do,” he added.

Two reports this year linked kratom use to various adverse effects, even death.

One study in the journal Clinical Toxicology found that between 2011 and 2017, more than 1,800 calls involving kratom were placed to U.S. poison control centers. The most common complaints were agitation/irritability and rapid heartbeat, followed by nausea, drowsiness, vomiting, confusion and high blood pressure. But there also were some reports of serious complications such as seizures, respiratory problems, coma and, in 11 instances, deaths. Nine of the deaths involved other drugs such as cocaine, fentanyl and alcohol, but two cases were attributed to kratom only.

Another report, from the Centers for Disease Control and Prevention, looked at more than 27,000 drug overdoses entered into a multistate database between July 2016 and December 2017 and found that 91 Americans died from overdoses involving kratom. Most of the cases involved multidrug use, including fentanyl, heroin and benzodiazepines. But in seven cases, kratom was the only compound revealed in post-mortem testing. The researchers, however, noted that “the presence of additional substances cannot be ruled out.”

Critics say these types of reports are hard to draw firm cause-and-effect conclusions from because other contributing factors may be at play.

The AKA maintains there have been no deaths directly resulting from kratom products that are unadulterated and have not been used in combination with other drugs. “Kratom has been safely used for centuries in Southeast Asia where there are no deaths associated with the pure kratom consumption,” Mac Haddow, the AKA’s senior fellow on public policy, said. “In the U.S., there are no deaths that are related to pure kratom consumption.”

What’s ahead for kratom?

While some health professionals support a kratom ban, others say regulation would be a better route.

Dr. Peter Grinspoon, a primary care doctor and instructor at Harvard Medical School, said banning kratom would leave many chronic pain sufferers without an option they may be relying on if they want to avoid prescription opioids or cannot get them from their physician.

Still, Grinspoon recommends that his patients avoid kratom because of the lack of regulation.

“If you buy kratom you don’t know what you’re getting,” he said. “Are you really getting a gram of kratom or are you getting a gram of whatever is in the capsules in the powder that they’re calling kratom? There’s no oversight of the growth, production, packaging, distribution or sales of kratom.”

Follow NBC HEALTH on Twitter & Facebook.

Jacqueline Stenson

NBC News contributor Jacqueline Stenson is a health and fitness journalist who has written for the Los Angeles Times, Reuters, Health, Self and Shape, among others. She also teaches at the UCLA Extension Writers’ Program.

Whole Earth Gifts

Home | Shop | Brands | Lab Tests | FAQ | Contact
Twitter | Facebook | Instagram | Youtube | Pinterest
1836 Kratom | Super Speciosa | KR8om | America Kratom Association | Kratomaton.com

 

The post What is Kratom? | Jacqueline Stenson | nbcnews.com | 10.16.19 appeared first on Whole Earth Gifts.

]]>
https://www.wholeearthgifts.com/what-is-kratom/feed/ 0